Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Obesity
Biotech
Amgen, trying to crash Novo party, posts obesity durability data
Recipients of the highest dose maintained double-digit percentage weight loss 150 days after receiving the last of three subcutaneous shots.
Nick Paul Taylor
Dec 5, 2022 8:30am
Boston Scientific snatches up gastro-focused Apollo for $615M
Nov 29, 2022 12:51pm
Overeating sweet treats? Scientists find what drives this desire
Oct 25, 2022 7:05am
Altimmune hits NASH target in phase 1 trial
Sep 14, 2022 11:45am
Gunning for China's obesity market, LeaderMed targets US IPO
Sep 1, 2022 6:35pm
Novo Nordisk to pilot obesity risk tests with Digbi Health
Aug 22, 2022 11:03am
